NCT00316732已完成不适用
Observational Sutdy to Assess the Effectiveness of Avodart in Subjects With Benign Prostatic Hyperplasia in Day to Day Clinical Practice
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 173
- 试验地点
- 1
研究概览
简要总结
This study was designed to assess the effectiveness of dutasteride in the actual clinical practice of prostate assessment clinics in the UK in accordance with best practice over a 12-month period.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Patients who not have received any pharmacological treatment or surgical interventions for BPH (Benign Prostatic Hyperplasia).
- •Patients should be prescribed dutasteride in compliance with the UK SmPC and BAUS guidelines on the treatment of BPH.
- •Patients must only enter the study after the decision to prescribe dutasteride has been undertaken.
- •Exclusion criteria: None specified
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)Benign Prostatic Hyperplasia (BPH)NCT00939120Siami, Paul F., M.D.46
已完成
3 期
A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic AlopeciaAlopeciaNCT00441116GlaxoSmithKline153
终止
2 期
Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate CancerProstate CancerNCT00985738University of Colorado, Denver16
已完成
4 期
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic HyperplasiaBenign Prostatic HyperplasiaNCT00701779Siami, Paul F., M.D.63
终止
4 期
Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without CatheterBenign Prostatic HyperplasiaNCT00421421GlaxoSmithKline276